|
HY-103081-10mg
|
MedChemexpress LLC
|
Beta-Glucuronidase-IN-1 [CAS 484006-66-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103081-5mg
|
MedChemexpress LLC
|
Beta-Glucuronidase-IN-1 [CAS 484006-66-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-10581-1g
|
MedChemexpress LLC
|
Gatifloxacin [CAS 112811-59-3]
|
|
COVID-19-anti-virus
|
|
|
HY-10581-5g
|
MedChemexpress LLC
|
Gatifloxacin [CAS 112811-59-3]
|
|
COVID-19-anti-virus
|
|
|
HY-10581-500mg
|
MedChemexpress LLC
|
Gatifloxacin [CAS 112811-59-3]
|
|
COVID-19-anti-virus
|
|
|
HY-10581A-1g
|
MedChemexpress LLC
|
Gatifloxacin (hydrochloride) [CAS 121577-32-0]
|
|
COVID-19-anti-virus
|
|
|
HY-10581A-5g
|
MedChemexpress LLC
|
Gatifloxacin (hydrochloride) [CAS 121577-32-0]
|
|
COVID-19-anti-virus
|
|
|
HY-10581A-500mg
|
MedChemexpress LLC
|
Gatifloxacin (hydrochloride) [CAS 121577-32-0]
|
|
COVID-19-anti-virus
|
|
|
HY-109591A-1mg
|
MedChemexpress LLC
|
Oleoyl coenzyme A (lithium) [CAS 188824-37-5]
|
|
|
|
|
HY-109591A-5mg
|
MedChemexpress LLC
|
Oleoyl coenzyme A (lithium) [CAS 188824-37-5]
|
|
|
|
|
HY-109785A-1mg
|
MedChemexpress LLC
|
(R)-Gyramide A (hydrochloride) [CAS 1793050-70-0]
|
|
|
|
|
HY-110354-10mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-110354-100mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-110354-25mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-110354-5mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-110354-50mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-111627-10mg
|
MedChemexpress LLC
|
5-Aza-7-deazaguanine [CAS 67410-64-4]
|
|
Cancer-programmed cell death
|
|
|
HY-111627-100mg
|
MedChemexpress LLC
|
5-Aza-7-deazaguanine [CAS 67410-64-4]
|
|
Cancer-programmed cell death
|
|
|
HY-111627-25mg
|
MedChemexpress LLC
|
5-Aza-7-deazaguanine [CAS 67410-64-4]
|
|
Cancer-programmed cell death
|
|
|
HY-111627-5mg
|
MedChemexpress LLC
|
5-Aza-7-deazaguanine [CAS 67410-64-4]
|
|
Cancer-programmed cell death
|
|
|
HY-111627-50mg
|
MedChemexpress LLC
|
5-Aza-7-deazaguanine [CAS 67410-64-4]
|
|
Cancer-programmed cell death
|
|
|
HY-113245-50mg
|
MedChemexpress LLC
|
3-Indolyl-Beta-D-glucuronide [CAS 35804-66-1]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-114818-10mg
|
MedChemexpress LLC
|
4-(tert-Butyl)-benzhydroxamic Acid [CAS 62034-73-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-114818-100mg
|
MedChemexpress LLC
|
4-(tert-Butyl)-benzhydroxamic Acid [CAS 62034-73-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-114818-5mg
|
MedChemexpress LLC
|
4-(tert-Butyl)-benzhydroxamic Acid [CAS 62034-73-5]
|
|
COVID-19-immunoregulation
|
|
